Hagtvedt Trond, Aaløkken Trond Mogens, Smith Hans-Jørgen, Graff Bjørn Anton, Holte Harald, Kolbenstvedt Alf
Department of Radiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Acta Radiol. 2010 Jun;51(5):555-62. doi: 10.3109/02841851003698198.
Previous studies of computed tomography (CT) enhancement of lymphomatous lymph nodes suggest that these nodes might have lower post contrast attenuation values than normal lymph nodes. We have previously found that the contrast medium enhancement curves of lymphomatous lymph nodes of the neck had significantly lower enhancement than those of presumably normal lymph nodes.
To prospectively compare CT contrast medium enhancement curves of a homogeneous population of 28 patients with lymphomatous lymph nodes of the neck with 20 controls; to compare enhancement curves before and after successful treatment and to compare nodes with Hodgkin lymphoma (HL) and nodes with non-Hodgkin lymphoma (NHL).
Twenty-eight consecutive patients (12 with HL) with lymphomatous lymph nodes of the neck and 20 control patients with sarcomas and presumably normal neck nodes underwent dynamic CT examinations. Seventeen of the patients in complete remission after lymphoma treatment were also examined.
The lymphomatous lymph nodes had significantly lower mean enhancement values than those of the control group (mean HU value at 90 s 77.9+/-10.5 HU and 93.4+/-15.3 HU, respectively, sensitivity 91% for values <92 HU at 90 s). Late enhancement values in the treated patients were significantly higher than those in the untreated patients. Patients with HL and patients with NHL had similar enhancement curves except that those with NHL had higher values at 7 min. No significant difference in mean percentage loss of enhancement was found between normal nodes and lymph nodes with HL before treatment, but there was a slightly significant difference between normal nodes and lymph nodes with NHL. No significant difference in percentage loss of enhancement was found between normal nodes and lymphomatous lymph nodes after treatment.
Dynamic CT examinations showed that lymphomatous lymph nodes had significantly lower mean enhancement values than those of the control group and confirmed the findings from a pilot study. Before treatment the mean enhancement values of HL were significantly higher than those of NHL at 7 min. There was no significant difference between the curves after treatment.
先前关于淋巴瘤性淋巴结的计算机断层扫描(CT)增强研究表明,这些淋巴结的对比剂后衰减值可能低于正常淋巴结。我们之前发现,颈部淋巴瘤性淋巴结的对比剂增强曲线的增强程度明显低于推测为正常的淋巴结。
前瞻性比较28例颈部淋巴瘤性淋巴结患者的同质人群与20例对照者的CT对比剂增强曲线;比较成功治疗前后的增强曲线,并比较霍奇金淋巴瘤(HL)淋巴结与非霍奇金淋巴瘤(NHL)淋巴结。
28例连续的颈部淋巴瘤性淋巴结患者(12例HL)和20例患有肉瘤且推测颈部淋巴结正常的对照患者接受了动态CT检查。17例淋巴瘤治疗后完全缓解的患者也接受了检查。
淋巴瘤性淋巴结的平均增强值明显低于对照组(90秒时的平均HU值分别为77.9±10.5 HU和93.4±15.3 HU,90秒时<92 HU值的敏感性为91%)。治疗患者的延迟增强值明显高于未治疗患者。HL患者和NHL患者的增强曲线相似,只是NHL患者在7分钟时的值更高。治疗前正常淋巴结与HL淋巴结之间的平均增强损失百分比无显著差异,但正常淋巴结与NHL淋巴结之间有轻微显著差异。治疗后正常淋巴结与淋巴瘤性淋巴结之间的增强损失百分比无显著差异。
动态CT检查显示,淋巴瘤性淋巴结的平均增强值明显低于对照组,并证实了一项初步研究的结果。治疗前,HL在7分钟时的平均增强值明显高于NHL。治疗后曲线之间无显著差异。